Marlon L. Perera, MD

Memorial Sloan Kettering Cancer Center

Dr Marlon Perera (MBBS, PhD, FRACS) is an Australian-trained urologist, currently completing an SUO Uro-oncology Fellowship at Memorial Sloan Kettering Cancer Center and is supported by a Australian-American Fulbright scholarship. Dr Perera has a strong interest in prostate cancer, PSMA-PET imaging and outcomes-based research and has published >150 peer-review publications.

Disclosure information not submitted.

Presentation(s):

• PD13-01: The continuing impact of the COVID-19 pandemic on prostate cancer management: A population based analysis

  Friday, May 13, 2022
  3:30 PM – 3:40 PM

• MP45-07: Oncologic Outcomes of Total Length Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer

  Sunday, May 15, 2022
  1:00 PM – 2:15 PM

• PD45-06: Urinary and sexual outcomes after Aquablation in men with benign prostate hyperplasia: A systematic review and meta-analysis

  Sunday, May 15, 2022
  1:50 PM – 2:00 PM

• MP51-18: Trends of primary staging for newly diagnosed prostate cancer – assessing the uptake of prostate specific membrane antigen positron emission tomography: A population based analysis

  Sunday, May 15, 2022
  4:30 PM – 5:45 PM

• MP57-07: Impact of the Minimally Invasive Approach on Morbidity of Salvage Radical Prostatectomy

  Monday, May 16, 2022
  10:30 AM – 11:45 AM

• MP58-18: Real world application and experience of a prostate specific antigen (PSA) machine learning model in a screening population

  Monday, May 16, 2022
  1:00 PM – 2:15 PM